Literature DB >> 24189844

Connective tissue diseases: To screen or not to screen for PAH in connective tissue diseases?

Janet E Pope1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24189844     DOI： 10.1038/nrrheum.2013.167

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

Review 1.  Pulmonary arterial hypertension in connective tissue diseases.

Authors:  Shunji Yoshida
Journal:  Allergol Int       Date:  2011-10-25       Impact factor: 5.836

2.  Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.

Authors:  Dinesh Khanna; Heather Gladue; Richard Channick; Lorinda Chung; Oliver Distler; Daniel E Furst; Eric Hachulla; Marc Humbert; David Langleben; Stephen C Mathai; Rajeev Saggar; Scott Visovatti; Nezam Altorok; Whitney Townsend; John FitzGerald; Vallerie V McLaughlin
Journal:  Arthritis Rheum       Date:  2013-12

3.  Changes in causes of death in systemic sclerosis, 1972-2002.

Authors:  Virginia D Steen; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

4.  Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease.

Authors:  Selim M Arcasoy; Jason D Christie; Victor A Ferrari; Martin St John Sutton; David A Zisman; Nancy P Blumenthal; Alberto Pochettino; Robert M Kotloff
Journal:  Am J Respir Crit Care Med       Date:  2002-12-12       Impact factor: 21.405

Review 5.  Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease management.

Authors:  E Hachulla; C P Denton
Journal:  Eur Respir Rev       Date:  2010-12

Review 6.  The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review.

Authors:  Chayawee Muangchan; Murray Baron; Janet Pope
Journal:  J Rheumatol       Date:  2013-07-15       Impact factor: 4.666

7.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

8.  Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.

Authors:  Virginia D Steen; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  J Rheumatol       Date:  2007-10-15       Impact factor: 4.666

9.  Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.

Authors:  Robin Condliffe; David G Kiely; Andrew J Peacock; Paul A Corris; J Simon R Gibbs; Florenc Vrapi; Clare Das; Charlie A Elliot; Martin Johnson; Julia DeSoyza; Chantal Torpy; Kim Goldsmith; Denise Hodgkins; Rodney J Hughes; Joanna Pepke-Zaba; J Gerry Coghlan
Journal:  Am J Respir Crit Care Med       Date:  2008-10-17       Impact factor: 21.405

10.  Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.

Authors:  J Gerry Coghlan; Christopher P Denton; Ekkehard Grünig; Diana Bonderman; Oliver Distler; Dinesh Khanna; Ulf Müller-Ladner; Janet E Pope; Madelon C Vonk; Martin Doelberg; Harbajan Chadha-Boreham; Harald Heinzl; Daniel M Rosenberg; Vallerie V McLaughlin; James R Seibold
Journal:  Ann Rheum Dis       Date:  2013-05-18       Impact factor: 19.103
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.